Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial
Titel:
Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial
Auteur:
Kerr, Rachel S Love, Sharon Segelov, Eva Johnstone, Elaine Falcon, Beverly Hewett, Peter Weaver, Andrew Church, David Scudder, Claire Pearson, Sarah Julier, Patrick Pezzella, Francesco Tomlinson, Ian Domingo, Enric Kerr, David J